Amylin Pharmaceuticals, Inc.
Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
Published in TB and Outbreaks Week, January 26th, 2010
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) announced the 2010 corporate priorities that will position the Company to address the dual epidemics of diabetes and obesity, achieve positive operating cash flow by the end of the year and place the Company on the path to operating profitability by the end of 2011. The news was presented by Daniel M. Bradbury, president and chief executive officer, at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
"Amylin's first-in-class diabetes products have been used by more than a million people living with diabetes. Through extraordinary science and our rich pipeline, Amylin has the potential to transform the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Cytokines
New cytokines study findings reported from University of Verona - Gastric Cancer
Study data from Keimyung University, Medical Department update knowledge of gastric cancer - Granuloma
Findings from S. Aly and co-researchers advance knowledge in granuloma - Highly Active Antiretroviral Therapy
Data on highly active antiretroviral therapy detailed by C.A.S. Schmaltz and co-authors - Hypertrophy
Investigators at Singapore National University have published new data on hypertrophy - Multidrug Resistant Tuberculosis
Research from Pusan National University reveals new findings on multidrug resistant tuberculosis - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
